Logo image of HOLX

HOLOGIC INC (HOLX) Stock Fundamental Analysis

NASDAQ:HOLX - Nasdaq - US4364401012 - Common Stock - Currency: USD

63.855  +0.59 (+0.94%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to HOLX. HOLX was compared to 187 industry peers in the Health Care Equipment & Supplies industry. HOLX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. A decent growth rate in combination with a cheap valuation! Better keep an eye on HOLX. These ratings could make HOLX a good candidate for value investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

HOLX had positive earnings in the past year.
HOLX had a positive operating cash flow in the past year.
HOLX had positive earnings in each of the past 5 years.
In the past 5 years HOLX always reported a positive cash flow from operatings.
HOLX Yearly Net Income VS EBIT VS OCF VS FCFHOLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

HOLX's Return On Assets of 6.51% is amongst the best of the industry. HOLX outperforms 88.24% of its industry peers.
HOLX has a better Return On Equity (12.05%) than 88.24% of its industry peers.
The Return On Invested Capital of HOLX (10.33%) is better than 92.51% of its industry peers.
HOLX had an Average Return On Invested Capital over the past 3 years of 11.66%. This is above the industry average of 7.89%.
Industry RankSector Rank
ROA 6.51%
ROE 12.05%
ROIC 10.33%
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
HOLX Yearly ROA, ROE, ROICHOLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

HOLX's Profit Margin of 13.83% is amongst the best of the industry. HOLX outperforms 91.44% of its industry peers.
In the last couple of years the Profit Margin of HOLX has declined.
With an excellent Operating Margin value of 24.43%, HOLX belongs to the best of the industry, outperforming 94.65% of the companies in the same industry.
HOLX's Operating Margin has improved in the last couple of years.
HOLX has a Gross Margin (56.44%) which is in line with its industry peers.
In the last couple of years the Gross Margin of HOLX has grown nicely.
Industry RankSector Rank
OM 24.43%
PM (TTM) 13.83%
GM 56.44%
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
HOLX Yearly Profit, Operating, Gross MarginsHOLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

HOLX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, HOLX has less shares outstanding
The number of shares outstanding for HOLX has been reduced compared to 5 years ago.
HOLX has a better debt/assets ratio than last year.
HOLX Yearly Shares OutstandingHOLX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
HOLX Yearly Total Debt VS Total AssetsHOLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

HOLX has an Altman-Z score of 3.81. This indicates that HOLX is financially healthy and has little risk of bankruptcy at the moment.
HOLX has a Altman-Z score of 3.81. This is in the better half of the industry: HOLX outperforms 74.87% of its industry peers.
The Debt to FCF ratio of HOLX is 2.61, which is a good value as it means it would take HOLX, 2.61 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.61, HOLX belongs to the top of the industry, outperforming 89.30% of the companies in the same industry.
HOLX has a Debt/Equity ratio of 0.54. This is a neutral value indicating HOLX is somewhat dependend on debt financing.
HOLX's Debt to Equity ratio of 0.54 is on the low side compared to the rest of the industry. HOLX is outperformed by 64.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 2.61
Altman-Z 3.81
ROIC/WACC1.26
WACC8.17%
HOLX Yearly LT Debt VS Equity VS FCFHOLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 3.24 indicates that HOLX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.24, HOLX is in line with its industry, outperforming 58.29% of the companies in the same industry.
HOLX has a Quick Ratio of 2.52. This indicates that HOLX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of HOLX (2.52) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.24
Quick Ratio 2.52
HOLX Yearly Current Assets VS Current LiabilitesHOLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.83% over the past year.
The Earnings Per Share has been growing by 10.83% on average over the past years. This is quite good.
The Revenue has been growing slightly by 1.66% in the past year.
Measured over the past years, HOLX shows a small growth in Revenue. The Revenue has been growing by 3.66% on average per year.
EPS 1Y (TTM)7.83%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%0%
Revenue 1Y (TTM)1.66%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%-1.23%

3.2 Future

The Earnings Per Share is expected to grow by 5.71% on average over the next years.
HOLX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.75% yearly.
EPS Next Y4.54%
EPS Next 2Y6.23%
EPS Next 3Y7.63%
EPS Next 5Y5.71%
Revenue Next Year1.24%
Revenue Next 2Y3.06%
Revenue Next 3Y3.77%
Revenue Next 5Y4.75%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HOLX Yearly Revenue VS EstimatesHOLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
HOLX Yearly EPS VS EstimatesHOLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.46, the valuation of HOLX can be described as correct.
84.49% of the companies in the same industry are more expensive than HOLX, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of HOLX to the average of the S&P500 Index (27.18), we can say HOLX is valued slightly cheaper.
The Price/Forward Earnings ratio is 13.87, which indicates a correct valuation of HOLX.
85.56% of the companies in the same industry are more expensive than HOLX, based on the Price/Forward Earnings ratio.
HOLX is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.34, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.46
Fwd PE 13.87
HOLX Price Earnings VS Forward Price EarningsHOLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

87.70% of the companies in the same industry are more expensive than HOLX, based on the Enterprise Value to EBITDA ratio.
HOLX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HOLX is cheaper than 91.44% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.67
EV/EBITDA 11.57
HOLX Per share dataHOLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of HOLX may justify a higher PE ratio.
PEG (NY)3.4
PEG (5Y)1.43
EPS Next 2Y6.23%
EPS Next 3Y7.63%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HOLX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HOLOGIC INC

NASDAQ:HOLX (7/16/2025, 1:07:40 PM)

63.855

+0.59 (+0.94%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners102.68%
Inst Owner Change-0.12%
Ins Owners0.78%
Ins Owner Change0.4%
Market Cap14.23B
Analysts70
Price Target68.28 (6.93%)
Short Float %2.53%
Short Ratio1.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.62%
Min EPS beat(2)-0.63%
Max EPS beat(2)-0.62%
EPS beat(4)1
Avg EPS beat(4)-0.3%
Min EPS beat(4)-2.26%
Max EPS beat(4)2.31%
EPS beat(8)5
Avg EPS beat(8)1.16%
EPS beat(12)9
Avg EPS beat(12)8.52%
EPS beat(16)13
Avg EPS beat(16)16.77%
Revenue beat(2)0
Avg Revenue beat(2)-1.83%
Min Revenue beat(2)-2.22%
Max Revenue beat(2)-1.44%
Revenue beat(4)0
Avg Revenue beat(4)-1.33%
Min Revenue beat(4)-2.22%
Max Revenue beat(4)-0.84%
Revenue beat(8)2
Avg Revenue beat(8)-0.77%
Revenue beat(12)6
Avg Revenue beat(12)1.68%
Revenue beat(16)10
Avg Revenue beat(16)5.33%
PT rev (1m)0%
PT rev (3m)-15.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.12%
EPS NY rev (1m)0.02%
EPS NY rev (3m)-1.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.36%
Valuation
Industry RankSector Rank
PE 15.46
Fwd PE 13.87
P/S 3.53
P/FCF 14.67
P/OCF 12.58
P/B 3.08
P/tB 44.34
EV/EBITDA 11.57
EPS(TTM)4.13
EY6.47%
EPS(NY)4.6
Fwd EY7.21%
FCF(TTM)4.35
FCFY6.82%
OCF(TTM)5.08
OCFY7.95%
SpS18.07
BVpS20.73
TBVpS1.44
PEG (NY)3.4
PEG (5Y)1.43
Profitability
Industry RankSector Rank
ROA 6.51%
ROE 12.05%
ROCE 13.02%
ROIC 10.33%
ROICexc 13.15%
ROICexgc 47.7%
OM 24.43%
PM (TTM) 13.83%
GM 56.44%
FCFM 24.09%
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
ROICexc(3y)16.74%
ROICexc(5y)19.65%
ROICexgc(3y)75.27%
ROICexgc(5y)85.91%
ROCE(3y)14.69%
ROCE(5y)19.22%
ROICexcg growth 3Y-27.14%
ROICexcg growth 5Y-3.18%
ROICexc growth 3Y-24.3%
ROICexc growth 5Y7.08%
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
F-Score8
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 2.61
Debt/EBITDA 1.93
Cap/Depr 54.33%
Cap/Sales 4.01%
Interest Coverage 250
Cash Conversion 88.34%
Profit Quality 174.26%
Current Ratio 3.24
Quick Ratio 2.52
Altman-Z 3.81
F-Score8
WACC8.17%
ROIC/WACC1.26
Cap/Depr(3y)40.46%
Cap/Depr(5y)40.59%
Cap/Sales(3y)3.27%
Cap/Sales(5y)3.37%
Profit Quality(3y)165.37%
Profit Quality(5y)135.66%
High Growth Momentum
Growth
EPS 1Y (TTM)7.83%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%0%
EPS Next Y4.54%
EPS Next 2Y6.23%
EPS Next 3Y7.63%
EPS Next 5Y5.71%
Revenue 1Y (TTM)1.66%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%-1.23%
Revenue Next Year1.24%
Revenue Next 2Y3.06%
Revenue Next 3Y3.77%
Revenue Next 5Y4.75%
EBIT growth 1Y11.01%
EBIT growth 3Y-26.89%
EBIT growth 5Y11.29%
EBIT Next Year13.56%
EBIT Next 3Y8.09%
EBIT Next 5Y6.92%
FCF growth 1Y15.42%
FCF growth 3Y-19.16%
FCF growth 5Y16.4%
OCF growth 1Y17.99%
OCF growth 3Y-17.99%
OCF growth 5Y14.62%